Leerink Partners analyst David Risinger reiterated a Market Perform rating on Pfizer (NYSE: PFE).The analyst comments "Bottom Line: Activist investor ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE